The Science
Why a copper peptide fades vascular dark circles where caffeine, retinol, and vitamin C cannot.
There are four types of dark circles. Three of them respond to conventional skincare. One of them — by far the most common in women 25–50 — doesn't, because it isn't a skincare problem in the conventional sense. It's a blood-vessel problem showing through thin skin. Peptina is built for that one.
The shadow you see is blood, not pigment.
Under-eye skin is among the thinnest skin on the body — roughly half the thickness of the skin on your cheek. Beneath it sits a dense capillary bed serving your eye area. When those capillaries weaken with age, hormone shifts, sun exposure, or simple genetics, two things happen: their walls thin, and they leak. The pooled blood and the visible vessels show through the thin skin above as a blue, purple, or red-brown shadow.
Caffeine eye creams constrict those vessels temporarily. Vitamin C brightens pigment that isn't there. Concealer hides the shadow but doesn't touch the cause. Retinol thickens skin slightly but doesn't address vascular integrity. None of these are bad ingredients — they just aren't tools built for the vascular mechanism.
The molecule that is built for it is GHK-Cu — copper tripeptide-1.
GHK-Cu: a carrier peptide that walks copper into the capillary wall.
Most peptides in skincare are signal peptides — short amino-acid chains that tell skin cells to produce more collagen. They're the workhorse behind every "anti-aging peptide" claim you've read. They are not the same molecule as GHK-Cu.
GHK-Cu is a carrier peptide. Its three-amino-acid sequence (glycyl-L-histidyl-L-lysine) wraps a copper ion in a stable bond and ferries it into the dermis. Once delivered, copper acts as a co-factor in the enzymatic crosslinking of collagen and elastin in capillary walls — the molecular "stitching" that makes the wall structurally resilient. Stronger walls leak less. Less leakage means less pooled blood. Less pooled blood means less shadow above.
This isn't theoretical. The pathway has been characterized in vascular biology for decades. The reason it took until now to land in a dermatology-grade eye product is that stabilizing GHK-Cu at a useful concentration is a chemistry problem most cosmetics labs route around.
What the published data actually shows.
The case for GHK-Cu on under-eye skin is built on three independent strands of evidence: a 12-week randomized controlled trial on facial application, a 28-day open-label trial specifically on fine-line/wrinkle endpoints, and a 2024 multi-center post-laser recovery study using GHK-Cu as the active. None of these are marketing claims by skincare brands. They are peer-reviewed clinical papers indexed in PubMed.
We cite these in good faith — none of them tested Peptina specifically, because Peptina is a 2026 launch. They test the molecule. What they establish is that GHK-Cu does what the mechanism predicts: it strengthens vascular wall integrity and supports capillary repair at clinically relevant concentrations.
Three ingredients you'd expect to find — and why they aren't in the bottle.
"The right molecule, at the right concentration, in the right packaging, on the right skin. Everything else is marketing."
What twelve weeks of twice-daily Peptina actually looks like.
The visible fade is not instant. Capillary wall remodeling happens at the speed biology allows — week 1–2 brings the cold-roller de-puff and the immediate barrier benefits of hyaluronic acid. Week 4–6 brings the early signal: the blue under your eyes thins, photos in even lighting start looking different. Week 8–12 is when the full result stabilizes; most customers stop reaching for concealer around then. After that, the protocol becomes maintenance — keep the capillaries supported, keep the shadow down.
Try the molecule on your own skin.
The 3-Bottle Kit covers the full 12-week build window. If your vascular dark circles haven't visibly faded by day 60, return whatever's left and we'll refund you in full.
Shop the Roll-On → Read our mission